RxDoctor Payments Data

Donelle Cummings, MD

Anatomic Pathology & Clinical Pathology · Brooklyn, NYNPI 1649539552

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (55.8%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Olympus Corporation Of The Americas at 41.7% of the total. 2025 is the largest year on record at $1,075, 2.2 times the $486 reported in 2019. Among anatomic pathology & clinical pathology clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,051in general payments, 2019–2025

Across 50 payments — averaging $61.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Olympus Corporation Of The Americas$1K
  • AbbVie$513
  • Pfizer$280
  • Covidien LP$242
  • Madrigal Pharmaceuticals$150
  • Dova Pharmaceuticals$143
  • plus $452 from 6 others

What the payments were for

  • Consulting fees$1104%
  • Travel & lodging$1,23841%
  • Food & beverage$1,70256%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,051 in reported general payments places this provider in the 90th percentile of 468 anatomic pathology & clinical pathology providers in New York.

See all anatomic pathology & clinical pathology providers in New York

Medicare billing

Part B allowed, 2024
$10,846
Medicare patients
34
Services billed
80

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Omeprazole24$365

Paid to pharmacies, not to this prescriber.

Other anatomic pathology & clinical pathology in Brooklyn

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →